Tiago P. Torres

Tiago P. Torres

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 301 publications

Correction: Comparative Data on Long-Term Efficacy of Biologics in Moderate-to-Severe AD: An Expert Perspective on Using Indirect Comparison Methodology.

Correction: Comparative Data on Long-Term Efficacy of Biologics in Moderate-to-Severe AD: An Expert Perspective on Using Indirect Comparison Methodology.

Journal: Dermatology and therapy

Published: August 07, 2026

Correction: The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.

Correction: The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.

Journal: Clinical reviews in allergy & immunology

Published: August 04, 2026

Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.

Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.

Journal: International journal of dermatology

Published: July 02, 2026

Extrapulmonary Tuberculosis Despite Preventive Therapy During Adalimumab for Psoriasis.

Extrapulmonary Tuberculosis Despite Preventive Therapy During Adalimumab for Psoriasis.

Journal: Clinical and experimental dermatology

Published: June 13, 2026

Global Healthcare Study on Psoriasis (GHSP): cohort profile and first findings.

Global Healthcare Study on Psoriasis (GHSP): cohort profile and first findings.

Journal: BMJ open

Published: May 19, 2026

Complete clearance of high-impact sites with risankizumab in patients with psoriasis: a 2-year real-world retrospective multicenter cohort study.

Complete clearance of high-impact sites with risankizumab in patients with psoriasis: a 2-year real-world retrospective multicenter cohort study.

Journal: The Journal of dermatological treatment

Published: May 06, 2026

Quality of life impairment in vitiligo: A comprehensive review of psychosocial and clinical determinants.

Quality of life impairment in vitiligo: A comprehensive review of psychosocial and clinical determinants.

Journal: The Journal of international medical research

Published: May 04, 2026

Correction to: Past, Present, and Future of Sodium Hypochlorite in Dermatology: A Scoping Review.

Correction to: Past, Present, and Future of Sodium Hypochlorite in Dermatology: A Scoping Review.

Journal: American journal of clinical dermatology

Published: April 18, 2026

The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.

The OX40-OX40L Co-Stimulatory Pathway as a Shared Driver of Immune Persistence in Skin and Airway Inflammation.

Journal: Clinical reviews in allergy & immunology

Published: April 16, 2026

Comparative Data on Long-Term Efficacy of Biologics in Moderate-to-Severe AD: An Expert Perspective on Using Indirect Comparison Methodology.

Comparative Data on Long-Term Efficacy of Biologics in Moderate-to-Severe AD: An Expert Perspective on Using Indirect Comparison Methodology.

Journal: Dermatology and therapy

Published: April 15, 2026

A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'".

A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'".

Journal: Dermatology and therapy

Published: April 07, 2026

Alopecia Areata: Current and Emerging Therapies.

Alopecia Areata: Current and Emerging Therapies.

Journal: Drugs

Published: March 14, 2026

Showing 1-12 of 301

Last Updated: 09/26/2026